Is Veracyte Stock a Good Addition to Your Portfolio Right Now? [Yahoo! Finance]
Veracyte, Inc. (VCYT)
Last veracyte, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.veracyte.com/investor-relations
Company Research
Source: Yahoo! Finance
A strong solvency position further adds optimism to the stock. However, headwinds from the ongoing biopharma challenges and broader macroeconomic issues pose risks for the company's operations. In the past year, this Zacks Rank #1 (Strong Buy) stock has outperformed the industry and the S&P 500. Shares have surged 67.3% compared with the industry's 5.9% growth and the S&P 500 composite's 24.4% rise. The renowned diagnostics company has a market capitalization of $3.26 billion. The company's earnings yield of 2.37% is well ahead of the industry's 3.3% yield. In the trailing four quarters, VCYT delivered an average earnings surprise of 520.6%. Positives for VCYT Stock Afirma Continues to Outperform: Veracyte's comprehensive A
Read more
Impact Snapshot
Event Time:
VCYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCYT alerts
High impacting Veracyte, Inc. news events
Weekly update
A roundup of the hottest topics
VCYT
News
- Veracyte (VCYT) Surged on Reporting Strong Earnings [Yahoo! Finance]Yahoo! Finance
- Veracyte Full Year 2024 Earnings: EPS Misses Expectations [Yahoo! Finance]Yahoo! Finance
- Top 3 Medical Instruments Industry Stocks to Ride the GenAI Boom [Yahoo! Finance]Yahoo! Finance
- Veracyte, Inc. (NASDAQ: VCYT) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Veracyte, Inc. (NASDAQ: VCYT) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $45.00 price target on the stock.MarketBeat
VCYT
Earnings
- 2/24/25 - Beat
VCYT
Sec Filings
- 3/10/25 - Form 4
- 3/10/25 - Form 4
- 3/10/25 - Form 4
- VCYT's page on the SEC website